DNA Explainer: How to administer 2-DG drug on COVID-19 patients, DRDO guidelines - The oral drug cleared by the Drugs Controller General of India on May 1 for emergency use, is an adjunct therapy to treat severe COVID-19 patients.
Price of DRDO s 2DG anti-COVID-19 drug fixed at Rs 990, government hospitals to get discount
INMAS-DRDO scientists in April 2020, conducted lab experiments with the Centre for Cellular and Molecular Biology (CCMB), Hyderabad. (Image Source: ANI)
Updated: May 28, 2021, 03:23 PM IST
The 2DG anti-COVID-19 drug by Defence Research and Development Organisation (DRDO) has been priced at Rs 990 per sachet by Dr Reddy s lab. As per ANI, the Central and state government hospitals would be provided with the medicine at a discounted price.
2DG (2 Deoxy-D-glucose) anti-COVID-19 drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of the Defence Research and Development Organisation (DRDO), in collaboration with Hyderabad-based pharma company Dr Reddy s Laboratories (DRL).